Register for email alerts and news feeds:
This journal | BMJ Group
rss
Annals of the Rheumatic Diseases 2001;60:511-513; doi:10.1136/ard.60.5.511
Copyright © 2001 BMJ Publishing Group Ltd & European League Against Rheumatism.
Ann Rheum Dis 2001;60:511-513 ( May )

Concise report

Reversibility of histological and immunohistological abnormalities in sublabial salivary gland biopsy specimens following treatment with corticosteroids in Sjögren's syndrome M M Zandbelta, F H J van den Hoogena, P C de Wildeb, P J S van den Bergc, H G F Schneiderd, L B A van de Puttea

a Department of Rheumatology, University Medical Centre St Radboud, Nijmegen, Netherlands, b Department of Pathology, University Medical Centre St Radboud, Nijmegen, c Department of Neurology, Sophia Hospital, Zwolle, Netherlands, d Department of Ophthalmology, Elkerliek Hospital, Helmond, Netherlands

Correspondence to: Dr M Zandbelt, Department of Rheumatology, UMC St Radboud, Nijmegen , P O Box 9101, 6500 HB Nijmegen, Netherlands M.Zandbelt{at}reuma.azn.nl

Accepted for publication 30 November 2000

Sjögren's syndrome (SS) is a chronic autoimmune disease characterised by specific lesions in exocrine glands, so sublabial minor salivary gland biopsy (SLGB) plays an important part in its diagnosis. The extent and composition of the lymphocytic infiltrate in SLGB specimens can be considered as target organ specific parameters. They are quantified after histological and immunohistological examination by a focus score (describing the extent of the infiltrate) and IgA% score (describing the composition of the infiltrate), respectively. However, little is known about the factors that contribute to the extent and composition of the infiltrate and whether these features are reversible as repeated SLGBs are rarely performed. A patient with SS is described who underwent SLGBs before and after treatment with high dose corticosteroids. After treatment there was not only clinical improvement, but also improvement in the histological and immunohistological parameters. Although these findings need to be confirmed in further studies, this suggests that histopathological changes may be reversible in SS. Furthermore, it shows that the potential effects of corticosteroid use should be taken into account when interpreting SLGB specimens. When clinical changes do parallel histological changes, repeated SLGBs might offer a marker for disease activity in patients with SS.


© 2001 by Annals of the Rheumatic Diseases

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Pijpe, J, Kalk, W W I, Bootsma, H, Spijkervet, F K L, Kallenberg, C G M, Vissink, A (2007). Progression of salivary gland dysfunction in patients with Sjogren's syndrome. Ann Rheum Dis 66: 107-112 [Abstract] [Full Text]  
  • van Woerkom, J. M., Kruize, A. A., Barendregt, P. J., Kater, L., Hene, R., Bootsma, H., Custers, R. J. H., Jacobs, J. W. G., Bijlsma, J. W. J. (2006). Clinical significance of quantitative immunohistology in labial salivary glands for diagnosing Sjogren's syndrome. Rheumatology (Oxford) 45: 470-477 [Abstract] [Full Text]  
  • Mori, K., Iijima, M., Koike, H., Hattori, N., Tanaka, F., Watanabe, H., Katsuno, M., Fujita, A., Aiba, I., Ogata, A., Saito, T., Asakura, K., Yoshida, M., Hirayama, M., Sobue, G. (2005). The wide spectrum of clinical manifestations in Sjogren's syndrome-associated neuropathy. Brain 128: 2518-2534 [Abstract] [Full Text]  
  • Pijpe, J, van Imhoff, G W, Vissink, A, van der Wal, J E, Kluin, P M, Spijkervet, F K L, Kallenberg, C G M, Bootsma, H (2005). Changes in salivary gland immunohistology and function after rituximab monotherapy in a patient with Sjogren's syndrome and associated MALT lymphoma. Ann Rheum Dis 64: 958-960 [Abstract] [Full Text]  
  • Ramos-Casals, M, Tzioufas, A G, Font, J (2005). Primary Sjogren's syndrome: new clinical and therapeutic concepts. Ann Rheum Dis 64: 347-354 [Abstract] [Full Text]  
  • Yamamoto, M., Harada, S., Ohara, M., Suzuki, C., Naishiro, Y., Yamamoto, H., Takahashi, H., Imai, K. (2005). Clinical and pathological differences between Mikulicz's disease and Sjogren's syndrome. Rheumatology (Oxford) 44: 227-234 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs